Fundz

Chimeron Bio Corp reported raising $1.2 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATENov 30, 2022

Amount Raised

$1.2 Million

$1.2 Million sold, per SEC Form D (first sale Oct 31, 2022)

Round Type

Seed

PhiladelphiaBiotechnology

Who to call at Chimeron Bio, and when

A new round usually means Chimeron Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Chimeron Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Chimeron Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Chimeron Bio. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Chimeron Bio

Location

601 WALNUT STREET, SUITE 715

Philadelphia, Pennsylvania, United States

About

Chimeron Bio is an early-stage biotech company focused on breakthrough treatments of cancer. Chimeron’s patented Multiplex nanoparticle and self-amplifying mRNA technology enables delivery of multiple genes to transform the complex tumor micro-environment with a unique “All-in-One” treatment approach. Chimeron is developing a high-impact pipeline for the creation and delivery therapeutics with the potential for meaningful patient results.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Chimeron Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Chimeron Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Chimeron Bio's next move

See what Strategic adds

Chimeron Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.